Platinum Sensitive Recurrent Ovarian Cancer Last updated on Feb 7, 2025 Previous OCEANS: Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer Next AURELIA Trial: Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer